In the Thick of It

What does it take for healthcare providers to meet the unique needs of HCM patients experiencing AFib? In this episode, Dr. Ethan Rowin and Dr. Jose Joglar delve into the critical topic of atrial fibrillation (AFib) in patients with hypertrophic cardiomyopathy (HCM). They discuss the heightened risk of stroke associated with AFib, the necessity for prompt anticoagulation, and the complexities of maintaining rhythm control. Tune in to gain pivotal insights into effective treatment strategies, including anti-arrhythmic medications and left atrial appendage closure devices, and discover the importance of comprehensive care and lifestyle management to improve outcomes for HCM patients facing AFib.
 
In the Thick of It is brought to you by the HCM Society and is produced by Earfluence.

In today’s episode of In the Thick Of It, Dr. Anna Woo is joined by Dr. Sharon Cresci for a conversation on hypertrophic cardiomyopathy and its genetic implications. What role does genetic testing play in identifying familial variants and whether inheriting a pathogenic variant will lead to disease? Learn about the importance of genetic testing, lifelong serial screening, collaborative treatment approaches, and the processes of educating patients and families about HCM. Tune in as these experts provide insights on vigilance, follow-up care, and informed decision-making in HCM management.

In the Thick of It is brought to you by the HCM Society and is produced by Earfluence.

On today's episode of 'In The Thick of It', Dr. Benjamin Van Boxtel welcomes Dr. Daniel Swistel and Dr. Joseph Dearani to discuss Septal Myectomy and mitral valve repair. Why is personalized patient care crucial when managing hypertrophic cardiomyopathy? Tune in as these specialists explore the importance of customized procedures, teamwork across disciplines, ongoing education, and staying abreast of the latest technological advancements in the field. Dr. Swistel and Dr. Dearani also explain the significance of comprehensive evaluations and specialist collaboration in treating HCM. But what obstacles do they encounter in their multidisciplinary efforts? Check out today's episode to discover their approaches to these challenges, and to learn how the latest surgical innovations are transforming treatment options for HCM and beyond.

In the Thick of It is brought to you by the HCM Society and is produced by Earfluence.

On this episode of 'In The Thick of It',  Dr. Steve Ommen joins Dr. Matthew Martinez to explain the latest changes and updates to the HCM guidelines. What is the importance of personalized patient care, shared decision-making, and lifestyle adjustments for HCM patients? Find out as Dr. Martinez and Dr. Ommen discuss risk assessment methodologies, effective management strategies for atrial fibrillation, and the evolving landscape of emerging medical therapies for HCM. These seasoned experts also dissect critical information from the new guidelines while drawing attention to key similarities and differences compared to prior guidelines. What impact do these new guidelines have on individuals affected by HCM across all age brackets? Join Dr. Martinez and Dr. Ommen as they explain how these updates aim to align clinical practices with the latest evidence, ensuring personalized and effective management of HCM.

In the Thick of It is brought to you by the HCM Society and is produced by Earfluence.

When should we make the critical decision to start Cardiac Myosin therapy in NYHA Class II HCM patients? Today, Dr. Patrycja Galazka is joined by Dr. Sara Saberi, Assistant Associate Professor in Cardiovascular Medicine and co-director of the Inherited Cardiomyopathy Program at the Frankel Cardiovascular Center. Together, we dive into the intricate world of Cardiac Myosin Inhibitors, addressing this vital question.

In the ever-changing landscape of HCM management, this episode offers a beacon of clarity. Whether you're a healthcare professional dedicated to improving patient outcomes or someone personally navigating the challenges of HCM, our conversation provides essential insights. Join us for a discussion that could reshape your approach to HCM care.

In the Thick of It is brought to you by the HCM Society and is produced by Earfluence.

How do you envision the role of gene therapy in shaping the future of cardiac care? In today’s episode, your host, Dr. Sharlene Day, engages in an enlightening conversation with Dr. Carolyn Ho, delving into the transformative world of gene therapy. Together, they navigate the complexities of gene therapy's fundamental concepts and potential applications in treating genetic cardiomyopathies and arrhythmia syndromes.

Remember, understanding the potential of gene therapy is just the beginning. Collectively, we can pave the way for transformative advancements in treating genetic heart conditions by staying informed and engaged.

In the Thick of It is brought to you by the HCM Society and is produced by Earfluence.

Are the symptoms of nonobstructive hypertrophic cardiomyopathy (nHCM) holding patients back from living their fullest lives? Join Dr. Melissa Lyle and Dr. Michelle Kittleson as they unravel the mysteries of nHCM symptoms like congestion, angina, and exercise intolerance. How can we better manage these symptoms and pave the way for improved quality of life?

Tune in as they explore innovative solutions, from advanced therapies to cutting-edge gene editing technologies like CRISPR, in the quest for better patient outcomes. Let's uncover the path to empowerment for nHCM patients together.

In the Thick of It is brought to you by the HCM Society, and is produced by Earfluence.

In today’s episode, Cardiologist Dr. Caroline Coats is talking with with Dr. James Moon, the CEO of Mycardium AI Ltd, and a distinguished Professor of Cardiology at University College London.  Dr. Moon’s groundbreaking work in cardiac MRI, especially in hypertrophic cardiomyopathy, has changed the way professionals understand and diagnose heart conditions. Today, we’re delving into his wealth of knowledge and experience on imaging in HCM. If you're ready to unlock the secrets of the heart and explore the cutting-edge developments in cardiology, stay tuned.

In the Thick of It is brought to you by the HCM Society, and is produced by Earfluence.

Our topic of discussion today is a critical one that impacts the world of cardiology and beyond cardiac myosin inhibitors. This cutting-edge area of research has the potential to revolutionize the way we approach cardiac diseases, and our experts are here to shed light on the latest developments, breakthroughs, and implications for patients and athletes alike.

So, whether you're a medical professional, a sports enthusiast, or simply someone interested in the intersection of sports and cardiology, you're in for a treat! Dr. Michael Ayers and Dr. Anjali Owens are here to share their insights, expertise, and passion for this groundbreaking field.

About our Host and Guest:
Dr. Michael Ayers is a sports cardiologist caring for hypertrophic cardiomyopathy patients, a genetic condition causing the thickening of the heart muscle.
Dr. Anjali Owens is a Medical Director, at the Center for Inherited Cardiac Disease and Associate Professor of Medicine (Cardiovascular Medicine) at the Hospital of the University of Pennsylvania

You’re listening to In the Thick of It, a podcast from the HCM Society, where we interview experts in the Hypertrophic Cardiomyopathy field, to broaden the awareness of new HCM studies & advancements!

In this episode, Dr. Robyn Bryde and Dr. Bradley Lander will interview each presenting author of the selected abstracts to tell us more about their HCM research. The guests are Dr. Said Alsidawi, Dr. Stuart Campbell, and Dr. Anjali Owens.

These abstract presentations were selected to encore at the 2023 HCMS Scientific Sessions on October 6.  Join us as three brilliant minds unravel the latest breakthroughs within HCM studies. This episode is your gateway to cutting-edge research. Stay tuned for a journey through innovation and discovery in the world of healthcare.

In the Thick of It is brought to you by the HCM Society, and is produced by Earfluence.